BayesianMCPMod (Q5978527): Difference between revisions
From MaRDI portal
Removed claims |
Added link to MaRDI item. |
||
(2 intermediate revisions by 2 users not shown) | |||
Property / programmed in | |||
Property / programmed in: R / rank | |||
Normal rank | |||
Property / depends on software | |||
Property / depends on software: R / rank | |||
Normal rank | |||
Property / depends on software: R / qualifier | |||
software version identifier: ≥ 4.2 | |||
Property / MaRDI profile type | |||
Property / MaRDI profile type: MaRDI software profile / rank | |||
Normal rank | |||
links / mardi / name | links / mardi / name | ||
Latest revision as of 20:10, 12 March 2024
Simulate, Evaluate, and Analyze Dose Finding Trials with Bayesian MCPMod
Language | Label | Description | Also known as |
---|---|---|---|
English | BayesianMCPMod |
Simulate, Evaluate, and Analyze Dose Finding Trials with Bayesian MCPMod |
Statements
Bayesian MCPMod (Fleischer et al. (2022) <doi:10.1002/pst.2193>) is an innovative method that improves the traditional MCPMod by systematically incorporating historical data, such as previous placebo group data. This R package offers functions for simulating, analyzing, and evaluating Bayesian MCPMod trials with normally distributed endpoints. It enables the assessment of trial designs incorporating historical data across various true dose-response relationships and sample sizes. Robust mixture prior distributions, such as those derived with the Meta-Analytic-Predictive approach (Schmidli et al. (2014) <doi:10.1111/biom.12242>), can be specified for each dose group. Resulting mixture posterior distributions are used in the Bayesian Multiple Comparison Procedure and modeling steps. The modeling step also includes a weighted model averaging approach (Pinheiro et al. (2014) <doi:10.1002/sim.6052>). Estimated dose-response relationships can be bootstrapped and visualized.
0 references
8 January 2024
0 references